Amgen (AMGN)
NASDAQ:AMGN

Amgen (AMGN) Stock Price & Analysis

4,818 Followers

AMGN Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$211.71 - $289.33
Previous Close$218.76
Volume1.71M
Average Volume (3M)2.37M
Market Cap
$116.89B
Enterprise Value$146.88B
Total Cash (Recent Filing)$31.60B
Total Debt (Recent Filing)$61.59B
Price to Earnings (P/E)14.9
Beta0.48
Aug 01, 2023
8.14 (3.72%)
Share Statistics
EPS (TTM)14.71
Shares Outstanding534,326,594
10 Day Avg. Volume2,898,615
30 Day Avg. Volume2,366,158
Standard Deviation0.07
R-Squared0.23
Alpha0.00269
Financial Highlights & Ratios
Price to Book (P/B)-4.62
Price to Sales (P/S)19.15
Price to Cash Flow (P/CF)27.80
P/FCF Ratio19.50
Enterprise Value/Market CapN/A
Enterprise Value/Revenue5.61
Enterprise Value/Gross Profit7.37
Enterprise Value/Ebitda16.13
Forecast
Price Target Upside15.40% Upside
Rating ConsensusHold
Number of Analyst Covering13


Financials

Annual

Risk Analysis

Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.

---

AMGN FAQ

What was Amgen’s price range in the past 12 months?
Amgen lowest stock price was $211.71 and its highest was $289.33 in the past 12 months.
    What is Amgen’s market cap?
    Currently, no data Available
    When is Amgen’s upcoming earnings report date?
    Amgen’s upcoming earnings report date is Aug 01, 2023 which is in 52 days.
      How were Amgen’s earnings last quarter?
      Amgen released its earnings results on Apr 27, 2023. The company reported $3.98 earnings per share for the quarter, beating the consensus estimate of $3.847 by $0.133.
        Is Amgen overvalued?
        According to Wall Street analysts Amgen’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Amgen pay dividends?
          Amgen pays a Quarterly dividend of $2.13 which represents an annual dividend yield of 3.69%. See more information on Amgen dividends here
            What is Amgen’s EPS estimate?
            Amgen’s EPS estimate is $4.48.
              How many shares outstanding does Amgen have?
              Amgen has 534,326,600 shares outstanding.
                What happened to Amgen’s price movement after its last earnings report?
                Amgen reported an EPS of $3.98 in its last earnings report, beating expectations of $3.847. Following the earnings report the stock price went down -0.248%.
                  Which hedge fund is a major shareholder of Amgen?
                  Among the largest hedge funds holding Amgen’s share is PRIMECAP Management Co. It holds Amgen’s shares valued at 4B.

                    ---

                    Amgen Stock Smart Score

                    The Amgen stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                    Learn more about TipRanks Smart Score

                    Company Description

                    Amgen

                    Founded in 1980, California-based Amgen, Inc. is one of the world's leading biotechnology companies, which is engaged in the discovery, development, manufacture and marketing of human therapeutics. It primarily focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology and neuroscience areas.

                    ---

                    Top 5 ETFs holding AMGN

                    Name
                    Market Value
                    Smart Score
                    Vanguard Total Stock Market ETF
                    $3.98B
                    8
                    Vanguard S&P 500 ETF
                    $3.00B
                    8
                    Invesco QQQ Trust
                    $1.56B
                    8
                    SPDR S&P 500 ETF Trust CDI
                    $1.33B
                    8
                    SPDR S&P 500 ETF Trust
                    $1.32B
                    8
                    Up to five ETFs with an Outperform Smart Score that hold AMGN. The ETFs are listed according to market value of AMGN within the ETF

                    ---

                    Forecast EPS vs Actual EPS


                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Regeneron
                    Biogen
                    Gilead Sciences
                    Bristol Myers

                    Popular Stocks

                    ---
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis